A recent study by Chen et al. 74, demonstrated in animal model that MM-MSCs promote the proliferation of tumor plasma cells through the inhibition of T-cell mediated immune responses via the PD-1 and PD-L1 pathway. The gene discussed is CD274; the disease is neoplasm.